@article{28780368dc5a43589da2835c358425ad,
title = "2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons",
keywords = "AHA Scientific Statements, acute coronary syndrome, anticoagulants, anticoagulation agents, antiplatelet agents, apixaban, atrial fibrillation, atrial flutter, cardioversion, coronary artery disease, coronary heart disease, dabigatran, edoxaban, focused update, hypertension, idarucizumab, myocardial infarction, obesity, percutaneous coronary intervention, risk factors, rivaroxaban, sleep apnea, stents, stroke, thromboembolism, warfarin",
author = "January, {Craig T.} and Wann, {L. Samuel} and Hugh Calkins and Chen, {Lin Y.} and Cigarroa, {Joaquin E.} and Cleveland, {Joseph C.} and Ellinor, {Patrick T.} and Ezekowitz, {Michael D.} and Field, {Michael E.} and Furie, {Karen L.} and Heidenreich, {Paul A.} and Murray, {Katherine T.} and Shea, {Julie B.} and Tracy, {Cynthia M.} and Yancy, {Clyde W.}",
year = "2019",
month = jul,
day = "9",
doi = "10.1161/CIR.0000000000000665",
language = "English (US)",
volume = "140",
pages = "e125--e151",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",
}
